1. Rising prevalence of osteoarthritis and hip fractures among the aging population.
2. Technological advancements in hip replacement implants leading to improved outcomes and reduced recovery time.
3. Increasing adoption of minimally invasive surgical procedures for hip replacement.
4. Growing demand for hip replacement implants in emerging economies due to improving healthcare infrastructure.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Application, End User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Johnson and Johnson Services, Medacta, DJO Global, Arthrex, MicroPort Scientific, Wright Medical Group N.V., Waldemar LINK & Co. KG, Corin, Zimmer, B. Braun Melsungen AG, DePuy Synthes, Smith and Nephew plc, Stryker |
1. High cost of hip replacement surgery and implants limiting access for a large portion of the population.
2. Concerns over the long-term durability and performance of hip replacement implants.
3. Stringent regulatory requirements and approval processes for new hip replacement implant technologies.